Apr 14, 2021 5:30am EDT Achieve Announces Publication of the ORCA-1 Phase 2b Clinical Trial of Cytisinicline in Adult Smokers in Nicotine and Tobacco Research
Mar 25, 2021 5:30am EDT Achieve Announces Publication of the RAUORA Head-to-Head Non-Inferiority Clinical Trial Comparing Cytisinicline and Chantix(R) (varenicline) in Addiction
Mar 16, 2021 5:30am EDT Achieve Life Sciences to Participate in M-Vest and Maxim Group Inaugural Emerging Growth Virtual Conference
Mar 15, 2021 6:30am EDT Achieve Life Sciences Announces Appointment of Dr. Bridget Martell and Dr. Cindy Jacobs to Board of Directors
Mar 11, 2021 4:05pm EST Achieve Reports Financial Results for Fourth Quarter and Year-End 2020 and Provides Corporate Update
Mar 04, 2021 5:30am EST Achieve Life Sciences to Announce Fourth Quarter and Year-End 2020 Financial Results and Host Conference Call and Webcast on March 11, 2021
Feb 24, 2021 6:30am EST Achieve Life Sciences Announces Presentation of Data on Smoker and E-Cigarette User Attitudes and Perceptions on Quitting at the Society for Research on Nicotine & Tobacco (SRNT) Annual Meeting
Feb 11, 2021 8:00am EST Achieve Life Sciences to Present at the MicroCap Rodeo Winter Wonderland Conference on February 16, 2021
Jan 07, 2021 5:30am EST Achieve Life Sciences to Present at H.C. Wainwright Virtual BioConnect Conference
Dec 07, 2020 4:05pm EST Achieve Life Sciences, Inc. Announces Closing of $17.3 Million Underwritten Public Offering, Including Full Exercise of Overallotment Option